On Mar 4th, 2014, Equities researchers at Piper Jaffray lifted their price objective on shares of LDR Holding Corp (NASDAQ:LDRH) from $27.00 to $33.00 in a research report issued on Friday, AmericanBankingNews.com reports. Piper Jaffray’s price target points to a potential upside of 4.60% from the company’s current price. LDR Holding Corp (NASDAQ:LDRH) stock opened at $39.67 in last trading session, and closed at $39.58, trading in the range of $36.98 – $40.38. The stock showed a positive weekly performance of 17.24%.
March 13, 2014 – Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor management will host a webcast and conference call the same day at 4:30 p.m. EDT (1:30 p.m. PDT) to discuss the financial results and provide a corporate update. Xencor Inc (NASDAQ:XNCR) shares closed at $13.68 on last trade day, by losing -1.58%. Stock 52 week range is $5.75 – $14.34. Company’s market capitalization is $374.73 million.
On Mar 7th, 2014, Albany Molecular Research (NASDAQ:AMRI) was upgraded by analysts at TheStreet from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Analyst Ratings Network.com reports. Albany Molecular Research, Inc. (NASDAQ:AMRI) stock advanced 5.85% and finished the last session at $17.18. The EPS of the stock remained 0.40. Company’s market capitalization is $542.85 million.
On Feb. 28, 2014) MEI Pharma Inc (NASDAQ:MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company’s investigational drug Pracinostat for the treatment of acute myeloid leukemia (AML). MEI Pharma Inc (NASDAQ:MEIP) stock opened at $10.53 in last trading session and closed at $10.71. The 52 week range of the stock is $6.52 – $12.45 and the day range was $10.51 – $11.00.